Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-043776
Filing Date
2014-06-26
Accepted
2014-06-26 14:08:25
Documents
1
Period of Report
2014-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 42774
  Complete submission text file 0001209191-14-043776.txt   45066
Mailing Address One Embarcadero Center San Francisco CA 94111
Business Address One Embarcadero Center San Francisco CA 94111 415-352-1520
CMEA Ventures VII LP (Reporting) CIK: 0001405712 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 14942297

Mailing Address C/O CMEA VENTURES VII GP LP ONE EMBARCADERO CENTER, SUITE 3250 SAN FRANCISCO CA 94111
Business Address C/O CMEA VENTURES VII GP LP ONE EMBARCADERO CENTER, SUITE 3250 SAN FRANCISCO CA 94111 415-352-1520
CMEA VENTURES VII (PARALLEL) LP (Reporting) CIK: 0001405972 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 14942296

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations